Italy: EU support for biotech’s red blood cell technology to treat rare diseases
©EryDelEIB awards €30 million loan to EryDel for development of novel RBC treatment of rare diseases. EryDel’s treatment platform under development for use in treating rare childhood diseases such as Ataxia Telangiectasia (AT). Financing supported und… read more

